Led by Gordon Tampol (CEO), Kasia Piskorska (CFO), Carlos Sanchez (CTO), and Darryl Glover (CCO), iSolve is dedicated to supporting organizations throughout the drug development lifecycle. By developing cutting edge Blockchain solutions that help align company initiatives with strategic partners, we will help organizations achieve their corporate goals and expand their enterprise. By providing Security, Visibility, and Proof of Process, via the power of the Blockchain, iSolve is able to provide solutions that enable partners to acquire the resources needed to grow or monitor their core business while promoting their expertise and strategy in a controlled environment
Our philosophy is simple: Provide ADLT™ solutions that are needed by the Biopharma and Healthcare industry to overcome their unique challenges throughout the drug development lifecycle and to improve the health and welfare of the global community. Our platform and other solutions provide the foundation for Biopharma companies, Investors, Service Providers, and Tech Transfer Offices to grow and prosper.
Our management team is comprised of highly skilled professionals with over 80 years of combined experience in Biopharma, Healthcare, Finance, Technology, , and Government. Our team has been able to develop and deploy a vision that caters to advancing companies by matching opportunities, ADLT™ solutions, and the required partners to support their current initiatives. As Entrepreneurs, Business Owners, and Experts in the field, we are currently striving to identify new market opportunities and develop solutions that position our clients for Growth and Success.